Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Volta Finance
March 2026 Monthly
3rd Mar 2026
NB Private Equity Partners
March 2026 Monthly
3rd Mar 2026
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
129: Why the bear view of AIM is overdone | Oliver Bedford of Hargreave Hale AIM VCT
Stay up-to-date with the latest research
Sign up to our newsletter
Watch on-demand now -
Event | Tax Advantaged Online Forum: Four distinct approaches to EIS investing
Latest Update
Our research can be accessed for free under MIFID.
Find out more >
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
Avacta Group plc
Life Sciences
De-risking of the partnership with Moderna
By
Dr Martin Hall
08 May 2017
Avacta Group plc
Life Sciences
Bringing forward the Affimer technology
By
Dr Martin Hall
05 May 2017
Stay up-to-date with the latest research
Sign up to our newsletter
Avacta Group plc
Life Sciences
Another important box ticked
By
Dr Martin Hall
12 Apr 2017
City of London Investment Group
Financials
Rising markets and improved performance
By
Dr Brian Moretta
12 Apr 2017
Redx Pharma
Life Sciences
CARB-X – new strategic collaboration
By
Dr Martin Hall
03 Apr 2017
Arbuthnot Banking Group Plc
Financials
History is repeating itself
By
Mark Thomas
28 Mar 2017
Diurnal Group Plc
Life Sciences
Commercial and development progresses
By
Dr Martin Hall
27 Mar 2017
Avacta Group plc
Life Sciences
Low response would be positive!
21 Mar 2017
Burford Capital
Financials
Another positive verdict
By
Dr Brian Moretta
20 Mar 2017
Advanced Oncotherapy
Life Sciences
Delivery of LIGHT
By
Dr Martin Hall
15 Mar 2017
Tissue Regenix
Life Sciences
Addressing woundcare in the US
13 Mar 2017
Prev
1
...
29
30
31
32
Next
